Autism trials in Japan
2 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum Disorder
- Where
- Hirakata, Kashihara, Miyakonojō, Ōta-ku, Yokohama, Kanagawa, Yoshinogari-cho, Kanzaki-gun
- Age
- 5 years to 17 years
- People
- 176 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07285798 · EU 2025-523188-39-00 - Phase 3Taking peopleA Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Where
- Bunkyo-ku, Chikugo, Miyakonojō, Ōta-ku, Sapporo, Yokohama, Kanagawa, Zentsujichó
- Age
- 5 years to 17 years
- People
- 400 worldwide
- Run by
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT07424404 · EU 2025-524062-16-00